United Laboratories International Holdings Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
United Laboratories International Holdings yıllık ortalama 33.8% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 5.7% annual. Gelirler growing yılda ortalama 12.6% oranında artmaktadır. United Laboratories International Holdings'in özkaynak karlılığı 21.4% ve net marjı 20.8%'dir.
Anahtar bilgiler
33.8%
Kazanç büyüme oranı
32.2%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 5.6% |
Gelir büyüme oranı | 12.6% |
Özkaynak getirisi | 21.4% |
Net Marj | 20.8% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Nov 11The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Oct 23Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Aug 30Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23Gelir ve Gider Dağılımı
United Laboratories International Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 14,009 | 2,908 | 2,120 | 108 |
31 Mar 24 | 13,875 | 2,805 | 2,255 | 54 |
31 Dec 23 | 13,740 | 2,701 | 2,389 | 0 |
30 Sep 23 | 13,399 | 2,469 | 2,475 | 48 |
30 Jun 23 | 13,059 | 2,236 | 2,561 | 96 |
31 Mar 23 | 12,197 | 1,909 | 2,456 | 48 |
31 Dec 22 | 11,334 | 1,581 | 2,350 | 0 |
30 Sep 22 | 10,750 | 1,288 | 2,376 | 20 |
30 Jun 22 | 10,166 | 995 | 2,402 | 39 |
31 Mar 22 | 9,935 | 991 | 2,368 | 20 |
31 Dec 21 | 9,703 | 988 | 2,334 | 0 |
30 Sep 21 | 9,445 | 1,056 | 2,304 | 20 |
30 Jun 21 | 9,187 | 1,123 | 2,273 | 40 |
31 Mar 21 | 8,980 | 913 | 2,248 | 20 |
31 Dec 20 | 8,772 | 703 | 2,222 | 0 |
30 Sep 20 | 8,690 | 626 | 2,175 | 22 |
30 Jun 20 | 8,607 | 549 | 2,128 | 44 |
31 Mar 20 | 8,500 | 595 | 2,172 | 22 |
31 Dec 19 | 8,393 | 642 | 2,216 | 0 |
30 Sep 19 | 8,100 | 765 | 2,147 | 9 |
30 Jun 19 | 7,808 | 888 | 2,077 | 19 |
31 Mar 19 | 7,659 | 785 | 1,958 | 9 |
31 Dec 18 | 7,511 | 683 | 1,839 | 0 |
30 Sep 18 | 7,395 | 373 | 1,779 | 28 |
30 Jun 18 | 7,280 | 64 | 1,719 | 56 |
31 Mar 18 | 7,053 | 73 | 1,697 | 28 |
31 Dec 17 | 6,827 | 82 | 1,675 | 0 |
30 Sep 17 | 6,640 | -34 | 1,688 | 3 |
30 Jun 17 | 6,454 | -150 | 1,702 | 5 |
31 Mar 17 | 6,266 | -211 | 1,687 | 3 |
31 Dec 16 | 6,078 | -272 | 1,672 | 0 |
30 Sep 16 | 6,083 | -216 | 1,671 | 5 |
30 Jun 16 | 6,076 | -159 | 1,667 | 9 |
31 Mar 16 | 6,195 | -32 | 1,663 | 5 |
31 Dec 15 | 6,446 | 92 | 1,695 | 0 |
30 Sep 15 | 6,597 | 148 | 1,684 | -12 |
30 Jun 15 | 6,711 | 201 | 1,665 | -23 |
31 Mar 15 | 6,565 | 373 | 1,621 | -12 |
31 Dec 14 | 6,422 | 545 | 1,577 | 0 |
30 Sep 14 | 6,179 | 552 | 1,505 | 4 |
30 Jun 14 | 6,101 | 574 | 1,473 | 8 |
31 Mar 14 | 6,112 | 306 | 1,452 | 4 |
31 Dec 13 | 5,972 | 38 | 1,396 | 0 |
Kaliteli Kazançlar: 3933 yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: 3933 'nin mevcut net kar marjları (20.8%) geçen yılın (17.1%) sinden daha yüksektir.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 3933 şirketinin kazançları son 5 yılda yılda 33.8% oranında önemli ölçüde arttı.
Büyüme Hızlandırma: 3933 'un son bir yıldaki kazanç büyümesi ( 30.1% ) 5 yıllık ortalamasının ( 33.8% /yıl) altındadır.
Kazançlar vs. Sektör: 3933 geçen yılki kazanç büyümesi ( 30.1% ) Pharmaceuticals sektörünün 6.4% değerini aştı.
Özkaynak Getirisi
Yüksek ROE: 3933 'nin Özsermaye Getirisi ( 21.4% ) yüksek olarak değerlendiriliyor.